Results 31 to 40 of about 7,921 (224)
Journal of Behçet Uz Children's Hospital, 2021 Objective: Treatment of childhood refractory epilepsy is a challenge for clinicians. Lacosamide is a new generation antiepileptic drug which is being used for focal onset seizures of adults and children.
Halil Ural Aksoy +5 more
doaj +1 more source
The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide [PDF]
, 2021 Purpose Optimal treatment with antiepileptic drugs (AEDs) is an important part of care for brain tumor patients with epileptic seizures. Lamotrigine and lacosamide are both examples of frequently used non-enzyme inducing AEDs with limited to no drug-drug
Opijnen, M.P. van +7 more
core +1 more source
A case of auditory disturbance caused by lacosamide
Epilepsy and Behavior Case Reports, 2019 We report a case of auditory disturbance in an adult female that developed after starting lacosamide treatment for epilepsy. While carbamazepine is known to change auditory pitch perception in some patients, that has not been previously reported as a ...
Mihoko Kawai, Kousuke Kanemoto
doaj +1 more source
Lacosamide-induced excessive laughing in a patient with Lennox–Gastaut syndrome
Epilepsy and Behavior Case Reports, 2018 Lacosamide is one of the third-generation antiseizure drugs that block voltage-gated sodium channels by enhancing slow inactivation. The most common adverse effects of lacosamide include dizziness, headache, nausea, vomiting, diplopia, fatigue, and ...
Hussein Algahtani +2 more
doaj +1 more source
Successful treatment of childhood prolonged refractory status epilepticus with lacosamide [PDF]
, 2011 Prolonged, refractory status epilepticus is a rare clinical syndrome that is associated with severe morbidity and mortality. Lacosamide is a newly approved medication for treatment of partial onset seizures in adults, which has a novel mechanism of ...
Tennison, Michael +7 more
core +1 more source
Lacosamide add-on Treatment in Refractory Focal Epilepsy: The Experience of a Single Tertiary Center [PDF]
, 2020 Objectives:Lacosamide is a third-generation antiepileptic agent that selectively enhances slow inactivation of sodium channels that take part in generation and propagation of action potentials and results in the diminution of neuronal excitability ...
Bülent Oğuz GENÇ +6 more
core +1 more source
Safety and efficacy of lacosamide versus phenytoin for refractory seizures in neurosurgical patients
BMJ Neurology Open, 2021 Background Postoperative neurosurgical patients have increased risk of seizures. Traditional anti-epileptics, such as phenytoin, are not always effective and cause adverse effects.
Sarah Schaidle +2 more
doaj +1 more source
Lacosamide in Pediatric Status Epilepticus [PDF]
, 2017 Investigators from Baylor College of Medicine studied the efficacy of lacosamide in pediatric status epilepticus (SE)
Juan A. Piantino
core +1 more source
Neonatal Cardiac Arrest Following Lacosamide Treatment: A Case Report
, 2023 Lacosamide is an antiepileptic drug with FDA approval for treatment of partial-onset seizures in patients above the age of 1 month. Lacosamide works by selective enhancement of proteins which induce preferential slow promotion of sodium channels to the ...
Melissa Ann Huberman +5 more
core +1 more source
CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY
Фармакоэкономика, 2016 Aims of study: 1) development of a model for forecasting of impact of Lacosamide administration for antiseizure therapy of local convulsions in patients, who are resistant to previous antiseizure therapy, for the account of healthcare and social security
E. A. Pyadushkina, M. Yu. Frolov
doaj +1 more source